Search

everythinglearnresearchcommunity

for

Search:↓

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Phytosomal nanocarriers can significantly increase the bioavailability of Cuscuta reflexa extract.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Treatment with dapsone, topical corticosteroids, and antibiotics improved the man's skin conditions.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

A systematic approach is crucial for managing hair loss in women.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Terbinafine can cause hair loss.

Treating hidradenitis suppurativa needs long-term care and teamwork among doctors, but there's a lack of strong guidance on how to do it.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Combining platelet-rich products, biomaterials, and bioactive substances may improve skin treatment, but more research is needed.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.